Biolight Life Sciences Ltd
TASE:BOLT
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
338.4
576
|
Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BOLT stock under the Base Case scenario is 27.22 ILS. Compared to the current market price of 449.5 ILS, Biolight Life Sciences Ltd is Overvalued by 94%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Biolight Life Sciences Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BOLT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Biolight Life Sciences Ltd
Balance Sheet Decomposition
Biolight Life Sciences Ltd
Current Assets | 14.1m |
Cash & Short-Term Investments | 4.5m |
Receivables | 659k |
Other Current Assets | 8.9m |
Non-Current Assets | 21.7m |
Long-Term Investments | 16.3m |
PP&E | 4.4m |
Intangibles | 686k |
Other Non-Current Assets | 251k |
Current Liabilities | 3.2m |
Accounts Payable | 2.7m |
Other Current Liabilities | 533k |
Non-Current Liabilities | 1.4m |
Long-Term Debt | 313k |
Other Non-Current Liabilities | 1m |
Earnings Waterfall
Biolight Life Sciences Ltd
Revenue
|
198k
ILS
|
Operating Expenses
|
-10.2m
ILS
|
Operating Income
|
-10m
ILS
|
Other Expenses
|
3.8m
ILS
|
Net Income
|
-6.2m
ILS
|
Free Cash Flow Analysis
Biolight Life Sciences Ltd
ILS | |
Free Cash Flow | ILS |
BOLT Profitability Score
Profitability Due Diligence
Biolight Life Sciences Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Biolight Life Sciences Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
BOLT Solvency Score
Solvency Due Diligence
Biolight Life Sciences Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Biolight Life Sciences Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BOLT Price Targets Summary
Biolight Life Sciences Ltd
Dividends
Current shareholder yield for BOLT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
BioLight Life Sciences Ltd. engages in the management, research and development, investments or sale of solutions, the purpose of which is to address a real need that exists in the field of eye diseases. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.
Contact
IPO
Employees
Officers
The intrinsic value of one BOLT stock under the Base Case scenario is 27.22 ILS.
Compared to the current market price of 449.5 ILS, Biolight Life Sciences Ltd is Overvalued by 94%.